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Abstract The purpose of this study was to compare the
effect of tooth related and patient related factors on the
success of non-surgical and surgical periodontal therapy. In
41 patients (22 female) with untreated and/or recurrent
periodontitis, no therapy, scaling and root planing (SRP), or
access flap (AF) were assigned according to probing pocket
depth (PPD). PPD and vertical relative attachment level
(RAL-V) were obtained initially, 3 and 6 months after
therapy. Baseline data were compared according to therapy,
jaw, tooth type, and site. Factors influencing clinical
parameters were identified using multilevel analyses.
Baseline PPDs were deeper interproximally, in the maxilla
and at premolars compared to buccal/oral sites, mandibular,
and anterior teeth. At 6 months, PPD reduction and RAL-V
gain were significantly greater at sites receiving SRP and
AF as compared to untreated sites (p<0.001). PPD
reduction and RAL-V gain were significantly less (p<
0.005) in smokers as compared to nosmokers and at
interproximal sites (p<0.0001) as compared to buccal/oral
sites. RAL-V gain was less in aggressive periodontitis, and
PPD reduction was less in the maxilla (p<0.001). In sites
with greater bone loss and infrabony defects, a poorer
response was observed regarding RAL-V gain or PPD
reduction, respectively. The conclusions of the study are the
following: (1) Nonsurgical and surgical periodontal thera-
pies are effective in single-rooted teeth; (2) severe inter-
proximal bone loss and infrabony defects deteriorate
clinical results; and (3) there seem to be more defect-
associated (tooth, site) factors influencing treatment out-





The major factor in the etiology of periodontitis is the
dental biofilm, i.e., bacterial plaque. Thus, the aim of anti-
infective periodontal therapy is the reduction in supra- and
subgingival microbial plaque to resolve periodontal inflam-
mation. Subgingival scaling and root planing (SRP) may
result in resolution of inflammation, reduced probing
pocket depths (PPD), and clinical attachment gain [1, 2,
16]. However, nonsurgical periodontal therapy, i.e., SRP, is
Clin Oral Invest (2007) 11:391–399
DOI 10.1007/s00784-007-0144-x
T.-S. Kim: A. Schenk
Section of Periodontology, Department of Conservative Dentistry,




Medical Informatics and Biostatistics Department,
University of Medicine and Pharmacy Timisoara,
300041 Timisoara, Romania
P. Reitmeir
Institute of Health Economics and Health Care Management,
GSF-National Research Center for Environment and Health,
85758 Neuherberg, Germany
P. Eickholz
Department of Periodontology, Center for Dental, Oral,
and Maxillofacial Medicine, University Hospital Frankfurt,
60590 Frankfurt, Germany
P. Eickholz (*)
Poliklinik für Parodontologie, Zentrum der Zahn-, Mund- und




e-mail: eickholz@med.uni-frankfurt.denot found to be successful at all treated sites. Although not
all factors influencing failure of nonsurgical therapy are
known, deep periodontal pockets [3, 21, 25, 28]a n d
furcation involvement [6, 9, 23] are some of them. Recent
meta-analyses have shown the efficacy of nonsurgical
therapy in moderate and deep periodontal pockets. In deep
pockets, access flap (AF) techniques result in better
reduction in PPD and clinical attachment gain [14, 15].
However, these meta-analyses like many other studies on
this issue before [3, 21, 25, 28] use mean values and are not
able to reflect the benefit of a particular technique at teeth
with certain defects, e.g., infrabony pockets. However,
calculation of a mean value, e.g., for PPD reduction, across
a patient in fact levels out tooth-related characteristics.
Even if separate strata for different baseline PPD are
considered, tooth-related factors other than baseline PPD
are leveled out also. This may lead to quite similar mean
values for nonsurgical and surgical therapy for a patient or
across a whole sample because tooth-related differences
between both approaches because of different amounts or
types of bone loss, jaw, etc. are leveled out. More recent
statistical methods such as the multilevel modeling are
considering single-tooth or even site characteristics while
still regarding the individual patient as a statistical unit. In a
structured review of 2002, it was explicitly stated that the
included studies showed similar results for nonsurgical and
surgical therapy after 1 year. However, insufficient studies
are available to evaluate the various treatment procedures,
e.g., in angular defects. Further, it is stated that subject
characteristics and their possible effect on treatment
outcome was not addressed in the studies available at that
time [14]. Thus, there is a need for more information on the
effect of patient and tooth-related factors on nonsurgical
and surgical periodontal therapy. Well known hypotheses
and the use of these more recent statistical methods may
lead to new information.
Clinical measurements in posterior are less reproducible
than in anterior teeth [7]. Furcation involvement is a known
factor to influence treatment outcome of nonsurgical and
surgical therapy. To provide a high level of reproducibility
of clinical measurements and to exclude a already known
influencing factor, only single-rooted teeth were considered
in this study.
The hypothesis behind this study is that different tooth-
related factors (e.g., tooth type, site, plaque, residual
inflammation, horizontal/vertical bone loss) and patient-
related factors (e.g., age, sex, diagnosis, smoking) deter-
mine the initial outcome of nonsurgical and surgical
periodontal therapy in single-rooted teeth.
Thus, the aim of the present study was to identify patient
and site factors that determine the initial outcome of
nonsurgical and surgical periodontal therapy in single-
rooted teeth using more recent statistical methods.
Materials and methods
Patients
The study group consisted of 41 patients (22 female)
suffering from moderate to severe periodontal disease.
These patients had been scheduled for periodontal treatment
within a randomized placebo-controlled clinical trial eval-
uating the effect of a subgingivally delivered 14% doxycy-
cline gel at the Section of Periodontology, Department of
Conservative Dentistry, Clinic for Oral, Dental and
Maxillofacial Diseases, University Hospital Heidelberg.
Each patient had to have three single-rooted teeth that
qualified as test teeth for the doxycycline study; that is,
only three teeth per patient were included into this study
[8]. Inclusion criteria were at least 23 years of age,
untreated moderate to severe periodontal disease or recur-
rent periodontitis without periodontal surgery at least for
the last 24 months, effective individual oral hygiene (plaque
control record<35%) [24], and written informed consent.
Exclusion criteria were local and/or systemic antibiotic
therapy within the last 6 months before the baseline
examination of the study, known adverse reactions to any
component of the test agent, anticoagulative therapy, liver,
kidney, gastroenteral diseases, pregnancy, and women who
were lactating. All patients were asked about current and
past cigarette consumption. A patient was classified as a
current smoker if he smoked one or more cigarettes per day
and as a former smoker if he had quit smoking for at least
5 years. Patients who had quit smoking within the last
5 years were classified current smokers. No more than 50%
of current smokers were allowed in the sample. All patients
were classified as chronic or aggressive periodontitis
according to the following criteria:
– Aggressive periodontitis: Patient is clinically healthy;
that is, systemic diseases predisposing for periodontitis
are not known; radiographic bone loss greater than or
equal to 50% in at least two different teeth and age less
that or equal to 35 years at time of diagnosis.
– Moderate and severe chronic periodontitis: attachment
loss greater than or equal to 3 mm and age greater than
35 years [19].
The study was approved by the Institutional Review
Boards for Human Studies of the University of Heidelberg.
Clinical examination
After completion of initial periodontal treatment including
oral hygiene instruction and supragingival scaling, PPD
were measured at four sites of every tooth. If a patient
fulfilled the inclusion criteria, the study protocol, risks,
benefits, and procedures were explained, and informed
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the Gingival Index (GI) and Plaque Index (PlI) [22] were
assessed at six sites (mesiobuccal, midbuccal, distobuccal,
distolingual, midlingual, mesiolingual) of every incisor,
canine, and premolar. PPD and vertical relative attachment
levels (RAL-V) were measured to the nearest 0.5 mm using
a straight periodontal probe (PCPUNC 15, Hu Friedy,
Chicago, IL) at six sites per tooth. A reference splint gave
the location of probing by notches and served as reference
for the RAL-V measurements. Bleeding on probing (BOP)
was recorded approximately 30 s after probing. After the
first course of measurements, all PPD and RAL-V measure-
ments were repeated. The means of the pairs of double
measurements were used for analysis. If a pair of PPD
double measurements showed a difference greater than
2 mm, a third measurement was performed at the respective
site (option 3). Then, the mean of the pair of the closer
measurements was taken for analysis at the respective site.
All clinical measurements before therapy were performed
by one examiner (Eickholz) who also performed active
periodontal therapy (subgingival debridement and surgery)
in all patients. Within each patient, three test teeth with
PPD=5 mm and BOP or PPD≥6 mm were selected for the
doxycycline study. These teeth were excluded from this
examination. Three and 6 months after therapy, the clinical
examinations were repeated in the same manner by a
second examiner (Kim) who did not have any information
about baseline data and the therapy [8].
Radiographic examination and evaluation
Before therapy, in 36 patients, full-mouth sets of periapical
radiographs (Ektaspeed plus; Kodac, Rochester, NY) were
obtained in XCP technique (XCP, Kentzler & Kaschner
Dental, Ellwangen/Jagst, Germany). Intraoral size 0 (max-
illary second incisors and mandibular anteriors) and 2 (all
other regions) dental films were exposed to an X-ray source
(Heliodent DS®, 60 kV, 7 mA, Sirona, Bensheim, Ger-
many) and developed under standardized conditions (XR
24 Nova®, Dürr Dental, Bietigheim–Bissingen, Germany).
All radiographs were viewed in a darkened room using a
radiograph screen (67-0420, Dentsply Rinn, Elgin, IL).
Each interproximal surface of single-rooted teeth was
classified for the type of bone loss (horizontal/vertical).
Further, the prevalence of a double contour of the root was
noted that was taken as indicative for a mesial or distal
groove. Relative bone loss in percent was assessed at two
sites per tooth (mesial and distal) using a Schei ruler [27].
This ruler consisted of six straight lines that divert in the
same angle. For each site, the basic line of the Schei ruler
was placed to the cementoenamel junction (CEJ) of the
respective tooth parallel to the occlusal plane. Then, the
ruler was moved until the sixth line was placed tangentially
to the apex. Finally, the alveolar crest was located. Location
between the two coronal lines meant bone loss up to 20%
of root length. Location between the second and third line
meant between 20 and 40% bone loss and so forth. If the
CEJ was destroyed or overlapped by interproximal restora-
tions, the restoration margin was used as reference. If the
alveolar crest could not be determined because of over-
lapping of adjacent teeth, the interproximal site was
classified as “cannot be assessed.” If an interproximal
surface showed a double contour, this was classified as an
interproximal root groove. All radiographic assessments
were performed by an examiner who was blinded to the
clinical measurements and therapy assignments (Schenk).
Therapy
Teeth exhibiting PPD<3 mm were treated neither by
subgingival SRP nor by AF [26]. SRP was performed
when PPD≥3 and ≤6 mm were present. If periodontal
surgery was necessary at teeth not adjacent to test teeth, this
was performed 1 week after SRP: AF was chosen for teeth
exhibiting PPD>6 mm. However, SRP was performed at all
test teeth (not included in this analysis) and the respective
neighboring teeth under local anesthesia with hand instru-
ments even for baseline PPD>6 mm. Thus, also some sites
with PPD>6 mm were treated exclusively by SRP. Further,
the decision to perform AF was taken per tooth and not per
site. Thus, also sites with PPD≤6 mm were treated by AF if
the respective tooth exhibited PPD>6 mm at one site.
Thereby, effectiveness of SRP and AF maybe analyzed
across the limits of indications as the ranges of PPD for the
three treatment groups in Table 4 demonstrate. Maintenance
including oral hygiene instruction and professional tooth
cleaning was done 3 months after test therapy.
Statistical analysis
Data handling
All data were entered into a personal computer program
(Systat™ for Windows version 10, Systat, Evanston, IL;
Schenk). Descriptive statistics were then calculated using
another program (SPSS™, version 10.0.1, SPSS, Chicago
IL) by an independent statistician (Lungeanu). Multilevel
analyses were modeled by another independent statistician
(Reitmeir) using a third program (SAS® version 6.12, SAS
Institute, Cary, NC).
Reproducibility
The replicate PPD and RAL assessments for all teeth were
used to estimate the intraexaminer reproducibility. The
intraexaminer reproducibility of PPD and RAL measure-
Clin Oral Invest (2007) 11:391–399 393ments was expressed as the standard deviation of single
measurements [4].
Treatment comparison
The individual patient was considered as a statistical unit in
this analysis. The main outcome variable for the compar-
ison of the therapeutic effects of no further therapy, SRP, or
AF was chosen to be the change of PPD. RAL-V was
considered as a secondary endpoint. All other clinical
parameters (GI, PlI) were control variables.
Only sites were included that could be assessed at all
three examinations. Additionally, baseline clinical parame-
ters were calculated separately according to therapy (no
therapy, SRP, AF), jaw, tooth type (anterior/premolar), and
site (interproximal/buccal and oral) and compared using
multilevel methodology [10, 11]. A probability p<0.05 was
accepted for a difference to be statistically significant.
Because of multiple testing, a Bonferroni correction was
performed: We tested 24 independent hypotheses on our set
of data. Thus, the statistical significance level that should
be used for each hypothesis separately is 1 of 24 times what
it would be if only one hypothesis were tested, i.e., p=
0.002. For all analyses, the basic level “site” was nested in
the upper level “tooth,” which itself was nested in the next
upper level “patient,” and patient effects on the outcome
were assumed to be random. This technique allows the
identification of single-tooth effects or parameters while
still considering the individual patient as a statistical unit
and the dependencies of site and tooth data within a patient
[10, 11]. Multilevel regressions were calculated including
only clinical parameters providing six measurements per
tooth first (site level: n=4,146; patient level: n=40). Further
analyses were performed that included also radiographic
parameters. Radiographic parameters were only available
for those patients contributing full-mouth radiographic
examinations and could be related only to interproximal
sites (mesiobuccal, mesiolingual, distolingual, mesiolin-
gual), i.e., four sites per tooth (site level: n=1,792; patient
level: n=36).
To identify factors influencing the treatment result,
change of RAL-V and PPD were analyzed by application
of a multilevel regression model using backward selection.
Models were fitted for the dependent variables (1) RAL-V
change after 6 months and (2) PPD change after 6 months
including the following independent variables: (1) clinical:
age, sex, actual smoking (yes/no), pack years, diagnosis
(aggressive/chronic periodontitis), jaw (maxilla/mandible),
site (interproximal/buccal or oral), tooth type (anterior/
premolar), therapy (none/SRP/AF), and PlI and GI at
baseline, (2) radiographic: interproximal bone loss in
percent, infrabony defect, and double contour of the root.
For the analysis including radiographic parameters, the
variable “site” (interproximal/buccal and oral) dropped out
because only interproximal sites remained in the analysis. A
probability p<0.15 was required for parameters to be kept
within the models.
Results
All 41 patients contributing 700 single-rooted teeth with
4,200 sites finished the 3-month re-examination. The
patient characteristics (age, diagnosis, smoking status) are
given in Table 1. From baseline to the 3-month examina-
tion, two single-rooted teeth were lost: one to an acute
periapical periodontitis and another because of prosthodon-
tic planning. After the 3-month re-examination, one patient
left the study. Only sites were included into the analysis,
which could be assessed at all three examinations: n=4,146
in 40 patients.
Table 1 Study population as related to age, sex, smoking habit, and
diagnosis
Variable Number (n=41) Percent
Age 45.9±10.9
Sex Female 22 53.7
Smoking Active 19 46.3
Former 12 29.3
Never 10 24.4
Diagnosis Aggressive 8 19.5
Table 2 Intraexaminer reproducibility at baseline, 3, and 6 months
examination
Examination Measurements (n) s (RAL-V) s (PPD)
Baseline 8,400 0.49 0.49
3 months 8,376 0.44 0.39
6 months 8,292 0.53 0.39
s Standard deviations of a single measurement
Table 3 Clinical parameters at baseline, 3 and 6 months after therapy
(mean±standard deviation)
Baseline 3 months 6 months
Sites 4,146 4,146 4,146
RAL-V (mm) 5.12±2.20 4.87±1.87 4.92±1.84
PPD (mm) 3.25±1.83 2.67±1.19 2.67±1.20
GI 0.78±0.97 0.51±0.86 0.51±0.86
PlI 0.16±0.51 0.32±0.70 0.37±0.74
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The results of the intraexaminer reproducibility of PPD and
RAL measurements as standard deviation of single mea-
surement for each examination time point are given in
Table 2.
Baseline data
The mean clinical parameters (RAL-V, PPD, PlI, GI) at
baseline over all sites are given in Table 3. The respective
data as related to therapy (no therapy, SRP, AF) are given in
Table 4. Whereas no statistically significant differences for
PlI were observed between the groups, RAL-V, PPD, and
GI of the SRP and AF sites revealed to be significantly (p<
0.001) greater as compared to untreated sites (Table 4).
Clinical parameters as related to jaw, tooth type, and site are
given in Table 5. Baseline RAL-V and PPD were
statistically significantly (p<0.001) greater in the maxilla
than in the mandible, whereas for PlI, it was vice versa
(Table 5). For tooth type, just baseline PPD was statistically
significantly (p<0.001) different between premolars and
anteriors with deeper pockets at the premolars (Table 5). All
baseline clinical parameters were observed to be statistical-
ly significantly (p<0.001) greater at the interproximal than
at the buccal and oral sites (Table 5).
Treatment effect
The healing phase passed uneventfully for all patients.
Clinical parameters as related to therapy after 3 and
6 months are given in Table 6, and their change after 3
and 6 months is given in Table 7. Whereas in untreated
sites, the study failed to observe any significant change,
SRP and AF resulted in PPD reduction and PAL-V gain
after 3 and 6 months (p<0.001; Table 7).
Prognostic factors
RAL-V gain was less favorable in current smokers, in
aggressive periodontitis, and at interproximal sites (Table 8).
PPD reduction was poorer in current smokers, at premolars,
in the maxilla, and at interproximal sites (Table 9). Whereas
baseline PPD was related to better PPD reduction and RAL-
V gain (p<0.0001), baseline RAL-V was related to better
RAL-V gain but to less favorable PPD reduction (Tables 8
and 9). Baseline PlI was associated with poorer PPD
reduction (p<0.15; Table 9). AF and SRP (p=0.0114) were
associated with better PPD reduction (Table 9).
Taking radiographic parameters into consideration, cur-
rent smoking resulted in less favorable and baseline PPD in
better RAL-V gain and PPD reduction, respectively
(Tables 10 and 11). Further, tooth type (premolar) and
Table 4 Clinical parameters at baseline as related to therapy (mean±standard deviation)
Sites No therapy SRP AF
1,440 Range 2,478 Range 198 Range
RAL-V/mm 4.35±1.82* 1.25–19.00 5.55±2.30 1.75–18.00 5.39±2.02 2.25–12.00
PPD/mm 2.45±1.13* 0.25–2.75 3.66±1.98 0.50–12.25 3.98±2.02 1.00–10.50
GI 0.48±0.84* 0.94±1.00 1.02±0.98
PlI 0.15±0.49 0.16±0.53 0.14±0.49
SRP Scaling and root planning, AF access flap
*Statistically significantly different from SRP and AF with p<0.001
Table 5 Clinical parameters at baseline as related to jaw (maxilla/mandible), tooth type (anterior/premolar), and site (interproximal/buccal and
oral) (mean±standard deviation)
Maxilla mandible premolar anterior interproximal buccal/oral
Sites 1,926 2,220 1,590 2,566 2,764 1,382
RAL-V/mm 5.24±2.14* 5.00±2.26 5.19±2.20* 5.07±2.22 5.37±2.26* 4.60±2.01
PPD/mm 3.55±1.88* 3.00±1.78 3.47±1.88* 3.12±1.81 3.67±1.82* 2.43±1.59
GI 0.80±0.98* 0.76±0.96 0.83±0.97* 0.75±0.96 0.89±0.98* 0.56±0.89
PlI 0.11±0.43* 0.19±0.57 0.14±0.48* 0.17±0.53 0.18±0.54* 0.11±0.44
*Statistically significantly different with p<0.001
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V gains (Table 10). Location in the maxilla and baseline PlI
resulted in less favorable PPD reduction (Table 11).
Generally, sites with greater interproximal bone loss
demonstrated poorer RAL-V gain (p=0.0001), and sites
with infrabony defects were associated with inferior PPD
reduction (p<0.0001; Tables 10 and 11).
Discussion
Study population
Patients treated in this study ranged from 23 to 71 years of
age with chronic and aggressive periodontitis. Original
measurements were performed in the setting of a random-
ized placebo-controlled clinical trial evaluating the effect of
a subgingivally delivered 14% doxycycline gel at the
Section of Periodontology, Department of Conservative
Dentistry, Clinic for Oral, Dental and Maxillofacial Dis-
eases, University Hospital Heidelberg. Each patient had to
provide three single-rooted teeth that qualified as test teeth
for the doxycycline study. To blind the examiner for the test
teeth, not only those but all single-rooted teeth were
assessed in all patients [8]. Despite the test teeth and their
direct neighbors, all single-rooted teeth were treated
according to the following criteria: Teeth exhibiting PPD<
3 mm were treated neither by subgingival SRP nor by AF.
SRP was performed when PPD≥3 mm was present. AF
was chosen for teeth exhibiting PPD>6 mm [21]. However,
teeth directly adjacent to test teeth were treated only by
SRP irrespective of baseline PPD. Thus, also some sites
with PPD>6 mm were treated exclusively by SRP. Further,
the decision to perform AF was taken per tooth and not per
site. Thus, also sites with PPD≤6 mm were treated by AF,
if they were located at a tooth with one or more sites with
PPD>6 mm. Thereby, effectiveness of SRP and AF may be
analyzed across the limits of indications as the ranges of
PPD for the three treatment groups in Table 4 demonstrate.
How could we exclude that the topically delivered
doxycycline had any influence on the treatment results of
the sites that were evaluated in this study? The subgingi-
vally delivered agent or vehicle control may be partially
absorbed and thereby have systemic effects at the other test
teeth. A pharmacokinetic study had found doxycycline only
in the blood of 1 of 16 patients [18]. Thus, a systemic
additional effect on the other teeth is quite unlikely. It has to
be kept in mind that in the sample investigated in this study,
only one tooth of the whole dentition per patient received
the active agent, i.e., doxycycline [8]. Further, amounts of
the subgingivally delivered substance may leave the pocket
via sulcus fluid and affect the other test teeth. Split-mouth
Table 6 Clinical parameters at 3 and 6 months after therapy as related to therapy (mean±standard deviation)
3 months after therapy 6 months after therapy
No therapy SRP AF No therapy SRP AF
Sites 1,440 2,478 198 1,440 2,478 198
RAL-V (mm) 4.37±1.76 5.13±1.90 5.14±1.64 4.47±1.76 5.17±1.85 5.11±1.61
PPD (mm) 2.33±0.96 2.84±1.25 3.09±1.34 2.35±1.05 2.83±1.24 2.99±1.27
GI 0.36±0.76 0.58±0.90 0.69±0.94 0.36±0.76 0.58±0.90 0.65±0.93
PlI 0.22±0.56 0.36±0.74 0.52±0.89 0.31±0.68 0.41±0.78 0.27±0.65
SRP Scaling and root planing, AF access flap
Table 7 Change of clinical parameters at 3 and 6 months after therapy as related to therapy (mean±standard deviation)
3 months after therapy 6 months after therapy
No therapy SRP AF No therapy SRP AF
Sites 1,440 2,478 198 1,440 2,478 198
RAL-V (mm) 0.03±0.74 0.41±1.11* 0.26±1.06* 0.12±0.94 0.38±1.20* 0.28±1.18*
PPD (mm) −0.11±0.72 −0.82±1.33* −0.89±1.25* 0.09±0.87 −0.82±1.40* −0.99±1.41*
GI −0.13±0.97 −0.36±1.14* −0.33±1.14* −0.13±1.03 −0.36±1.18* −0.36±1.44*
PlI 0.08±0.69 0.20±0.82* 0.37±0.97* 0.16±0.75 0.25±0.87* 0.13±0.68*
SRP Scaling and root planing, AF access flap
*Statistically significantly different from no therapy with p<0.001
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topical antibiotics have made the provision that teeth
selected as test sites should be separated by at least one
tooth [8, 12], minimizing the interaction between therapy
modes. In a pharmacokinetic study from control sites, much
smaller amounts of doxycycline could be detected in the
gingival crevicular fluid than from another site that had
received the particular doxycycline gel subgingivally in the
same dentition [20]. Thus, it is unlikely that the topical
doxycycline had any additional effect on the treatment
results of all teeth but the test teeth.
Treatment effect
The results observed in this study after SRP are in
agreement with observations reported by other authors 3
and 6 months after nonsurgical debridement of single-
rooted teeth [2, 6]. Our PPD reductions and RAL-V gains
achieved 6 months after therapy confirm data by a meta-
analysis on nonsurgical vs surgical periodontal therapy that
reports PPD reduction of 1.07 mm and vertical attachment
(PAL-V) gains of 0.6 mm at sites with baseline PPD 4–
6 mm 6 months after SRP. However, PPD reductions
6 months after AF for mean baseline PPD of 5.4 mm were
1.0 mm which is less than the meta analysis lists for
baseline PPD 4–6 mm: PPD reduction 1.37 mm. PAL-V
gain after AF was 0.3 mm which comes quite close to the
0.31 mm reported by the meta analysis [15]. Serino et al.
report results 12 months after treatment [28]. For baseline
PPD 4–5 mm they report PAL-V gains of 0.31 mm and
PPD reduction of 1.1 mm after non-surgical as well as
0.21 mm and 1.6 mm after surgical therapy. This is quite
similar to the results of this study regarding PAL-V gain
and PPD reduction after SRP. However, the PPD reduction
after surgical therapy is more favorable than ours [28].
Prognostic factors
Current smoking was generally associated with less
favorable PPD reduction and RAL-V gain in all models.
Smoking is the most significant external risk factor for
periodontitis [5, 13, 29] and is known to deteriorate the
results of periodontal therapy in general [7, 30]. However,
smoking was the only patient-associated factor that was
kept in all models. The diagnosis of aggressive periodonti-
tis was associated with less favorable RAL-V gains,
whereas it was not kept in the models to explain PPD
reduction. It is interesting to note that the other patient-
associated factors, i.e., age and sex, were kept in neither
model. This confirms observations of D’Aiuto et al. [5].
It is interesting to note that the diagnosis of aggressive
periodontitis affected RAL-V gains but not PPD reduction.
Table 8 Backward multilevel linear regression analysis—dependent variable: RAL-V reduction 6 months after therapy, n=40 patients, 4,146 sites
Estimate SE df F value p value
Intercept −1.8776 0.1068 37
Current smoking −0.2875 0.1106 3,427 6.76 0.0094
Site (interproximal) −0.2341 0.0277 3,427 71.28 <0.0001
Aggressive periodontitis −0.2903 0.1308 3,427 4.93 0.0265
Baseline PPD 0.2746 0.0158 3,427 303.72 <0.0001
Baseline RAL-V 0.1832 0.0141 3,427 169.61 <0.0001
Table 9 Backward multilevel linear regression analysis—dependent variable: PPD reduction 6 months after therapy, n=40 patients, 4,146 sites
Estimate SE df F value p value
Intercept −1.6487 0.1037 38
Current smoking −0.3312 0.1055 3,451 9.86 0.0017
Jaw (maxilla) −0.1299 0.0324 3,451 16.05 <0.0001
Site (interproximal) −0.3664 0.0262 3,451 195.10 <0.0001
Tooth type (premolar) −0.0501 0.0338 3,451 2.20 0.1381
Baseline PPD 0.6162 0.0146 3,451 1774.31 <0.0001
Baseline RAL-V −0.0354 0.0128 3,451 7.63 0.0058
Baseline Plaque Index −0.0368 0.0244 3,451 2.27 0.1318
Scaling and root planing 0.1171 0.0392 3,451 4.48 0.0114
Access flap 0.0997 0.0861 3,451 4.48 0.0114
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tis have a higher risk for recessions than patients with
chronic periodontitis.
Several tooth- and site-associated factors were identified
by multilevel analysis to influence clinical outcomes.
Generally, baseline PPD was related to better PPD
reduction and RAL-V gain (p<0.0001). PPD reduction
and RAL-V gain was less pronounced in the premolars and
at interproximal sites (p<0.15), and PPD reduction was less
pronounced in the maxilla (p<0.001). These results are
plausible because compared to anterior teeth, premolars are
less accessible and interproximal sites are more difficult to
debride than oral and lingual sites. Less favorable PPD
reduction in premolars than in incisors was also recently
reported by other authors [5]. However, D’Aiuto et al.
observed more favorable PPD reduction at interproximal
sites, whereas this study observed the contrary. The
multilevel analysis performed in this study was adjusted
for baseline PPD. Baseline pockets were deeper interprox-
imally than at buccal or palatal/lingual sites. This might
explain more favorable PPD reduction at interproximal sites
without adjusting for baseline PPD. Considering the
different therapies, SRP and AF provided better PPD
reduction than no therapy. However, the analysis failed to
reveal statistically significant differences between both
therapies in single-rooted teeth. It seems that AF provides
no advantages over SRP in single-rooted teeth.
Taking radiographic parameters into consideration, cur-
rent smoking and baseline PPD were kept in the models.
However, the greater the interproximal bone loss, the
poorer the RAL-V gain (p<0.0001), and infrabony defects
were associated with inferior PPD reduction (p<0.0001).
Total amount of bone loss seems to be associated with poor
prognosis of the respective tooth generally irrespective of
the type of treatment. This has also been observed for long-
term stability [17]. D’Aiuto et al. [5] did not assess
radiographic parameters. However, they considered tooth
mobility and found mobility was correlated with less
favorable PPD reduction. It is interesting to note that
interproximal grooves that had been assessed as root double
contours failed to influence the outcomes of therapy. Up to
our best knowledge, this is the first analysis on the
influence of baseline bone loss on the outcome of
nonsurgical or surgical periodontal therapy that does not
use patient means but individual tooth parameters.
Within the limitations of the present study the following
conclusions may be drawn: (1) Nonsurgical and surgical
periodontal therapies are effective in single-rooted teeth; (2)
severe interproximal bone loss and infrabony defects
deteriorate the clinical results, and (3) there seem to be
more defect-associated (tooth, site) factors influencing
treatment outcome than patient-associated factors.
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Table 10 Multilevel linear regression analysis—dependent variable: RAL-V reduction 6 months after therapy, n=36 patients, 1,796 sites
Estimate SE df F value p-value
Intercept −1.8290 0.1385 33
Current smoking −0.3758 0.1334 1,313 7.94 0.0049
Tooth type (premolar) −0.0763 0.0502 1,313 2.31 0.1292
Aggressive periodontitis −0.3311 0.1635 1,313 4.10 0.0431
Baseline PPD 0.2371 0.0256 1,313 85.86 <0.0001
Baseline RAL-V 0.2637 0.0242 1,313 118.36 <0.0001
Bone loss in % −0.0115 0.0016 1,313 50.58 <0.0001
Table 11 Multilevel linear regression analysis—dependent variable: PPD reduction 6 months after therapy, n=36 patients, 1,796 sites
Estimate SE df F value p value
Intercept −2.0771 0.1364 34
Current smoking −0.4646 0.1197 1,313 15.08 0.0001
Jaw (maxilla) −0.1469 0.0433 1,313 11.51 0.0007
Baseline PPD 0.6286 0.0119 1,313 2791.95 <0.0001
Baseline Plaque Index −0.0550 0.0332 1,313 2.75 0.0097
Infrabony defect −0.2932 0.0671 1,313 19.10 <0.0001
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